Synthetic Human Insulin, Denmark, 2000

Made:
1999-2000
maker:
Novo Nordisk

Vial of Human Monotard, monocompetent insulin, 10ml, by Novo Nordisk A/S, Bagsvaerd, Denmark, 1999-2000.

People with diabetes must inject insulin to manage their blood sugar levels. They also need to monitor their blood glucose levels, to avoid levels that are too high (hyperglycaemia), or too low (hypoglycaemia). This synthetic ‘human’ insulin suspension was manufactured by Novo Nordisk. A dose was injected into the abdominal wall to ensure fast absorption into the blood. It is an ‘intermediate-acting’ insulin that delivers a dose over a number of hours.

Frederick Banting (1891–1941) and Charles Best (1899-1978) were Canadian researchers at the University of Toronto. They first isolated insulin in 1921. The only insulin available until the 1960s was sourced from animals.

Details

Category:
Therapeutics
Object Number:
2000-651
Materials:
aluminium (metal), glass, materia medica, paper (fibre product)
type:
insulin
taxonomy:
  • drug
credit:
Guy's Hospital

Cite this page

Rights

We encourage the use and reuse of our collection data.


Data in the title, made, maker and details fields are released under Creative Commons Zero


Descriptions and all other text content are licensed under a Creative Commons Attribution 4.0 licence

Using our data

Download

Download catalogue entry as json

Download manifest IIIF

Our records are constantly being enhanced and improved, but please note that we cannot guarantee the accuracy of any information shown on this website.